• +1 (732) 369 9777
  • +1 (609) 857 6083
  • enquiry@dimensionmarketresearch.com

logo In Vitro Diagnostics (IVD) Market

Comprehensive Industry Landscape and Strategic Outlook

  • About Us
  • Insight
    Trending Reports Latest Reports
  • Industries
    Aerospace & Defence
    Agriculture & Horticulture
    Automotive
    BFSI & Education
    Chemical & Material
    Consumer Goods
    Electrical & Semiconductor
    ICT & TMT
    Energy & Power
    Food & Beverages
    Industry Automation & Equipment
    Manufacturing & Construction
    Medical Devices & Healthcare IT
    Metals & Minerals
    Packaging & Logistics
    Pharmaceuticals & Healthcare
    Sports & Fitness
  • News And Media
  • Contact us
Speak to Analyst
Request Free Sample
/images/logo.png
  • home
  • Pharmaceuticals & Healthcare
  • In Vitro Diagnostics (IVD) Market

In Vitro Diagnostics (IVD) Market By Product (Instruments, Reagents, Services), By Technology, By Application, By End User, By Test Location - Global Industry Outlook, Key Companies (Abbott, Siemens Healthcare, Qiagen, and others), Trends and Forecast 2023-2032

Published on : November-2023  Report Code : RC-554  Pages Count : 254  Report Format : PDF
Overview Table of Content Download Report's Excerpt Request Free Sample

Market Overview

The Global In Vitro Diagnostics (IVD) Market is expected to reach a value of USD 106.9 billion in 2023, and it is further anticipated to reach a market value of USD 202.9 billion by 2032 at a CAGR of 7.4.%

In Vitro Diagnostics (IVD) Market Growth Analysis
In vitro diagnostics (IVDs) are medical tests used to identify diseases, conditions, & infections. The term "in vitro" means "in glass," indicating that these tests are performed in controlled laboratory settings using test tubes & similar equipment, which sets them apart from "in vivo" tests, which are conducted inside the body. IVDs are essential tools for diagnosing and monitoring various health issues, offering a non-invasive and precise way to assess a person's health.

The field of In Vitro Diagnostics (IVD) is undergoing exciting developments, with significant events and conferences shedding light on future trends. At the 2024 AdvaMed MedTech Conference, experts highlighted the importance of innovations such as AI, digital integration, and point-of-care (POC) testing, which are transforming disease detection, monitoring, and management​. 

Additionally, the World Health Organization's Strategic Advisory Group on IVDs held its meeting in November 2024, focusing on improving access to essential diagnostic tools globally​. Meanwhile, in China, the China Association of In-Vitro Diagnostics (CAIVD) hosted multiple conferences exploring strategic advancements and collaborations within the IVD sector​. These gatherings reflect the industry's drive to enhance precision medicine and make diagnostics more accessible to diverse populations.

Market Dynamic

The global IVD market's growth is influenced by many key factors, like the prevalence of chronic & infectious diseases is notably high, allowing a surge in the demand for diagnostic procedures, which is further strengthened by the increasing use of point-of-care (POC) diagnostics & the integration of advanced technologies in in-vitro diagnostic products. 

In addition, there is a growth in awareness & acceptance of personalized medicine and companion diagnostics, driving the market's expansion.
 
Moreover, the market has seen a transition from traditional diagnostics to cutting-edge approaches working at the genetic level, owing to advanced technologies like molecular diagnostics, genetic testing, polymerase chain reaction (PCR), & next-generation sequencing (NGS) being integrated into the IVD platform.

However, despite these developments, certain challenges hinder market growth. Stringent regulations governing product approvals & complex reimbursement procedures create obstacles to the industry's progress, yet even after these hurdles, the IVD market continues to evolve & expand, driven by its essential role in diagnosing & managing a wide range of health conditions.

Research Scope and Analysis

By Product

The reagent products lead in driving the global market, also claiming the largest share of revenue in 2023. Furthermore, this segment is anticipated to maintain its dominant position throughout the forecasted period, which enduring success can be attributed to the substantial R&D efforts undertaken by major industry players to create innovative reagents. 

In addition, the introduction of kits designed for rapid cancer detection allows companies to look at specialized & profitable niches within the In Vitro Diagnostics (IVD) sector, focusing on cutting-edge reagents & targeted diagnostics highlighting the segment's major role in advancing the IVD field & its potential to impact healthcare by facilitating faster & more accurate disease identification.

By Technology

Based on technology, the molecular diagnostics category secures the major market share, primarily driven by the introduction of groundbreaking products & ongoing technological developments. Further, as traditional PCR (Polymerase Chain Reaction) methods typically require complex equipment, substantial research endeavors within this sector have allowed pioneering innovations, like plasmofluidic chips, which are incredibly compact, roughly the size of a postage stamp. 

These innovations have revolutionized the field by providing more efficient & streamlined testing solutions, showing the dynamic nature of molecular diagnostics. As a result, this segment has emerged as the market leader, showcasing its critical role in the ongoing evolution of diagnostic technologies & its impact on healthcare & disease detection.

By Application

In 2023, the infectious disease application category stands out as the dominant segment within the market, holding the largest share. In Vitro Diagnostics (IVDs) play a major role in identifying the microorganisms responsible for infectious diseases, with a main focus on life-threatening infections like HIV/AIDS, tuberculosis, hepatitis, & pneumonia. 

Further, major players in the market are forming collaborative partnerships focusing on enhancing the availability of cutting-edge laboratory services, ensuring patients & healthcare providers have access to high-quality, innovative diagnostic solutions, which not only advances the industry's capabilities but also strengthens the overall healthcare ecosystem, ultimately enhancing the diagnosis & management of infectious diseases, which continue to be a significant global health concern.

By End User

Considering its different uses, the global market is categorized into laboratories, hospitals, home care, & other sectors, the laboratory segment takes the lead in 2023, commanding the major share of revenue, which is attributed to growing awareness surrounding personalized medicine, an increase in demand for cost-effective services, & notable technological advancements. 

These factors are anticipated to drive the growth of the laboratory segment, which is a primary revenue driver due to the significant volume of testing activities conducted within laboratory settings, which also underlines the essential role of laboratories in the market, highlighting their contribution to advancing healthcare through testing & diagnostic services.

By Test Location

In terms of test location, the point-of-care test location category emerges as the leader in terms of revenue in 2023, securing the highest share, which is attributed to the growing need for quick disease detection near patients, expediting critical decision-making in healthcare. This growth in demand has allowed manufacturers to develop portable, compact, swift, & user-friendly testing devices, easing their use in non-laboratory settings. 

As a result, the market is experiencing a growth in user-friendly & readily transportable instruments, catering to the trend of conducting diagnostic tests closer to the patient, which not only improves the accessibility & efficiency of healthcare but also shows the importance of quick and accurate disease identification in diverse healthcare settings.

In Vitro Diagnostics (IVD) Market Testing Analysis

The In Vitro Diagnostics (IVD) Market Report is segmented on the basis of the following:

By Product

  • Instruments
  • Reagents
  • Services

By Technology

  • Molecular Diagnostics
  • Immunoassay
  • Microbiology
  • Hematology
  • Clinical Chemistry
  • Coagulation
  • Others

By Application

  • Infectious Disease
  • Diabetes
  • Oncology
  • Nephrology
  • Cardiology
  • Drug Testing
  • Autoimmune Disease
  • Others

By End User

  • Laboratories
  • Hospitals
  • Home Care
  • Others

By Test Location

  • Point of Care
  • Home Care
  • Others

Regional Analysis

North America leads in the global IVD market, contributing a substantial 42.2% of the total revenue in 2023, and is expected to maintain its dominant position in the forecasted period, which is driven by factors like the growth in the number of chronic diseases, a rapidly growing elderly population, substantial healthcare funding, & government support. The rising demand for customized healthcare through genetic testing, mainly for conditions like diabetes & cancer, is anticipated to further boost the market in North America.

In Vitro Diagnostics (IVD) Market Regional Analysis

Also, Asia Pacific plays a significant role in the 2023 market, with promising growth prospects for the future, as it is projected to be the fastest-growing regional market due to factors such as strong & stabilizing economies, government policies that encourage healthcare development, a burgeoning middle-class population, and rapid urbanization. In vitro diagnostics tests in this region are crucial for diagnosing heart-related disorders, infectious diseases, and cancer, among other health concerns, making it a key growth area for the industry.

By Region

North America
  • The U.S.
  • Canada
Europe
  • Germany
  • The U.K.
  • France
  • Italy
  • Russia
  • Spain
  • Benelux
  • Nordic
  • Rest of Europe
Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • ANZ
  • ASEAN
  • Rest of Asia-Pacific
Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of Latin America
Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Israel
  • Egypt
  • Rest of MEA

Competitive Landscape

The In Vitro Diagnostic market comprises many companies operating both globally & regionally, resulting in a diverse & competitive landscape, as there are numerous international & local companies looking for their share of the market. As a result, the industry doesn't have a major dominant player but is shared among various competitors. These players come in different sizes & strengths, making the market's structure diverse and varied, reflecting a mixture of global and regional influences on its dynamics.

In March 2023, Abbott revealed that its Alinity i laboratory device, built to diagnose traumatic brain injuries (TBIs) & look for concussions using two specific biomarkers, has got the green light from the FDA for commercial release, which means the instrument will be now authorized for use & sale in the market. The device's approval shows a significant step forward in enhancing the diagnosis & assessment of TBIs & concussions, creating a valuable tool for healthcare professionals to improve patient care in these critical areas.

Some of the prominent players in the global In Vitro Diagnostics (IVD) Market are:
  • Siemens Healthcare
  • Abbott
  • Sysmex Corp
  • bioMerieux
  • Qiagen
  • Danaher Corp
  • Quest Diagnostics
  • Becton Dickinson (BD)
  • Quidel Corp
  • Grifols
  • Other Key Players

COVID-19 Pandemic & Recession: Impact on the Global In Vitro Diagnostics (IVD) Market

The COVID-19 pandemic had a higher impact on the Global In Vitro Diagnostics (IVD) market. Demand for IVD tests, like PCR & antibody tests, increased as they became critical tools for diagnosing & monitoring the virus, which boosted the IVD market temporarily. However, the recession caused by the pandemic led to a decline in healthcare budgets & halt in non-essential medical procedures, affecting the long-term growth of the IVD market. 

As healthcare systems adapted to the pandemic, there was a growing focus on quick point-of-care testing solutions. These challenges & opportunities have reshaped the IVD market landscape, emphasizing the importance of flexibility & innovation in addressing future healthcare crises.

                                      Report Characteristics
Market Size (2023) USD 106.9 Bn
Forecast Value (2032) USD 202.9 Bn
CAGR (2023-2032) 7.4%
Historical Data 2017 - 2022
Forecast Data 2023 - 2032
Base Year 2022
Estimate Year 2023
Report Coverage Market Revenue Estimation, Market Dynamics, Competitive Landscape, Growth Factors and etc.
Segments Covered By Product (Instruments, Reagents, and Services), By Technology (Molecular Diagnostics, Immunoassay, Microbiology, Hematology, Clinical Chemistry, Coagulation, and Others), By Application (Infectious Disease, Diabetes, Oncology, Nephrology, Cardiology, Drug Testing, Autoimmune Disease, and Others), By End User (Laboratories, Hospitals, Home Care, and Others), By Test Location (Point of Care, Home Care, and Others)
Regional Coverage North America – The US and Canada; Europe – Germany, The UK, France, Russia, Spain, Italy, Benelux, Nordic, & Rest of Europe; Asia- Pacific– China, Japan, South Korea, India, ANZ, ASEAN, Rest of APAC; Latin America – Brazil, Mexico, Argentina, Colombia, Rest of Latin America; Middle East & Africa – Saudi Arabia, UAE, South Africa, Turkey, Egypt, Israel, & Rest of MEA
Prominent Players Siemens Healthcare, Abbott, Sysmex Corp, bioMerieux, Qiagen, Danaher Corp. Quest Diagnostics, Becton Dickinson (BD), Quidel Corp, Grifols, and Other Key Players
Purchase Options We have three licenses to opt for: Single User License (Limited to 1 user), Multi-User License (Up to 5 Users), and Corporate Use License (Unlimited User) along with free report customization equivalent to 0 analyst working days, 3 analysts working days and 5 analysts working days respectively.

 

Frequently Asked Questions

  • How big is the Global In Vitro Diagnostics (IVD) Market?

    The Global In Vitro Diagnostics (IVD) Market size is estimated to have a value of USD 106.9 billion in 2023 and is expected to reach USD 202.9 billion by the end of 2032.

  • Which region accounted for the largest Global In Vitro Diagnostics (IVD) Market?

    North America dominates the Global In Vitro Diagnostics (IVD) Market with a share of 42.2% in 2023.

  • Who are the key players in the Global In Vitro Diagnostics (IVD) Market?

    Some of the key players in the Global In Vitro Diagnostics (IVD) Market are Abbott, Siemens Healthcare, Qiagen, and many others.

  • What is the growth rate in the Global In Vitro Diagnostics (IVD) Market?

    The market is growing at a CAGR of 7.4 percent over the forecasted period.

  • Contents

      1.Introduction
        1.1.Objectives of the Study
        1.2.Market Scope
        1.3.Market Definition and Scope
      2.In Vitro Diagnostics (IVD) Market Market Overview
        2.1.Global In Vitro Diagnostics (IVD) Market Market Overview by Type
        2.2.Global In Vitro Diagnostics (IVD) Market Market Overview by Application
      3.In Vitro Diagnostics (IVD) Market Market Dynamics, Opportunity, Regulations, and Trends Analysis
        3.1.Market Dynamics
          3.1.1.In Vitro Diagnostics (IVD) Market Market Drivers
          3.1.2.In Vitro Diagnostics (IVD) Market Market Opportunities
          3.1.3.In Vitro Diagnostics (IVD) Market Market Restraints
          3.1.4.In Vitro Diagnostics (IVD) Market Market Challenges
        3.2.Emerging Trend/Technology
        3.3.PESTLE Analysis
        3.4.PORTER'S Five Forces Analysis
        3.5.Technology Roadmap
        3.6.Opportunity Map Analysis
        3.7.Case Studies
        3.8.Opportunity Orbits
        3.9.Pricing Analysis
        3.10.Ecosystem Analysis
        3.11.Supply/Value Chain Analysis
        3.12.Covid-19 & Recession Impact Analysis
        3.13.Product/Brand Comparison
      4.Global In Vitro Diagnostics (IVD) Market Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by By Product, 2017-2032
        4.1.Global In Vitro Diagnostics (IVD) Market Market Analysis by By Product: Introduction
        4.2.Market Size and Forecast by Region
        4.3.Instruments
        4.4.Reagents
        4.5.Services
      5.Global In Vitro Diagnostics (IVD) Market Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by By Technology, 2017-2032
        5.1.Global In Vitro Diagnostics (IVD) Market Market Analysis by By Technology: Introduction
        5.2.Market Size and Forecast by Region
        5.3.Molecular Diagnostics
        5.4.Immunoassay
        5.5.Microbiology
        5.6.Hematology
        5.7.Clinical Chemistry
        5.8.Coagulation
        5.9.Others
      6.Global In Vitro Diagnostics (IVD) Market Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by By Application, 2017-2032
        6.1.Global In Vitro Diagnostics (IVD) Market Market Analysis by By Application: Introduction
        6.2.Market Size and Forecast by Region
        6.3.Infectious Disease
        6.4.Diabetes
        6.5.Oncology
        6.6.Nephrology
        6.7.Cardiology
        6.8.Drug Testing
        6.9.Autoimmune Disease
        6.10.Others
      7.Global In Vitro Diagnostics (IVD) Market Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by By End User, 2017-2032
        7.1.Global In Vitro Diagnostics (IVD) Market Market Analysis by By End User: Introduction
        7.2.Market Size and Forecast by Region
        7.3.Laboratories
        7.4.Hospitals
        7.5.Home Care
        7.6.Others
      8.Global In Vitro Diagnostics (IVD) Market Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by By Test Location, 2017-2032
        8.1.Global In Vitro Diagnostics (IVD) Market Market Analysis by By Test Location: Introduction
        8.2.Market Size and Forecast by Region
        8.3.Point of Care
        8.4.Home Care
        8.5.Others
      10.Global In Vitro Diagnostics (IVD) Market Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Region, 2017-2032
        10.1.North America
          10.1.1.North America In Vitro Diagnostics (IVD) Market Market: Regional Analysis, 2017-2032
            10.1.1.1.The US
            10.1.1.2.Canada
        10.2.1.Europe
          10.2.1.Europe In Vitro Diagnostics (IVD) Market Market: Regional Trend Analysis
            10.2.1.1.Germany
            10.2.1.2.France
            10.2.1.3.UK
            10.2.1.4.Russia
            10.2.1.5.Italy
            10.2.1.6.Spain
            10.2.1.7.Nordic
            10.2.1.8.Benelux
            10.2.1.9.Rest of Europe
        10.3.Asia-Pacific
          10.3.1.Asia-Pacific In Vitro Diagnostics (IVD) Market Market: Regional Analysis, 2017-2032
            10.3.1.1.China
            10.3.1.2.Japan
            10.3.1.3.South Korea
            10.3.1.4.India
            10.3.1.5.ANZ
            10.3.1.6.ASEAN
            10.3.1.7.Rest of Asia-Pacifc
        10.4.Latin America
          10.4.1.Latin America In Vitro Diagnostics (IVD) Market Market: Regional Analysis, 2017-2032
            10.4.1.1.Brazil
            10.4.1.2.Mexico
            10.4.1.3.Argentina
            10.4.1.4.Colombia
            10.4.1.5.Rest of Latin America
        10.5.Middle East and Africa
          10.5.1.Middle East and Africa In Vitro Diagnostics (IVD) Market Market: Regional Analysis, 2017-2032
            10.5.1.1.Saudi Arabia
            10.5.1.2.UAE
            10.5.1.3.South Africa
            10.5.1.4.Israel
            10.5.1.5.Egypt
            10.5.1.6.Turkey
            10.5.1.7.Rest of MEA
      11.Global In Vitro Diagnostics (IVD) Market Market Company Evaluation Matrix, Competitive Landscape, Market Share Analysis, and Company Profiles
        11.1.Market Share Analysis
        11.2.Company Profiles
        11.3.Siemens Healthcare
          11.3.1.Company Overview
          11.3.2.Financial Highlights
          11.3.3.Product Portfolio
          11.3.4.SWOT Analysis
          11.3.5.Key Strategies and Developments
        11.4.Abbott
          11.4.1.Company Overview
          11.4.2.Financial Highlights
          11.4.3.Product Portfolio
          11.4.4.SWOT Analysis
          11.4.5.Key Strategies and Developments
        11.5.Sysmex Corp
          11.5.1.Company Overview
          11.5.2.Financial Highlights
          11.5.3.Product Portfolio
          11.5.4.SWOT Analysis
          11.5.5.Key Strategies and Developments
        11.6.bioMerieux
          11.6.1.Company Overview
          11.6.2.Financial Highlights
          11.6.3.Product Portfolio
          11.6.4.SWOT Analysis
          11.6.5.Key Strategies and Developments
        11.7.Qiagen
          11.7.1.Company Overview
          11.7.2.Financial Highlights
          11.7.3.Product Portfolio
          11.7.4.SWOT Analysis
          11.7.5.Key Strategies and Developments
        11.8.Danaher Corp
          11.8.1.Company Overview
          11.8.2.Financial Highlights
          11.8.3.Product Portfolio
          11.8.4.SWOT Analysis
          11.8.5.Key Strategies and Developments
        11.9.Quest Diagnostics
          11.9.1.Company Overview
          11.9.2.Financial Highlights
          11.9.3.Product Portfolio
          11.9.4.SWOT Analysis
          11.9.5.Key Strategies and Developments
        11.10.Becton Dickinson (BD)
          11.10.1.Company Overview
          11.10.2.Financial Highlights
          11.10.3.Product Portfolio
          11.10.4.SWOT Analysis
          11.10.5.Key Strategies and Developments
        11.11.Quidel Corp
          11.11.1.Company Overview
          11.11.2.Financial Highlights
          11.11.3.Product Portfolio
          11.11.4.SWOT Analysis
          11.11.5.Key Strategies and Developments
        11.12.Grifols
          11.12.1.Company Overview
          11.12.2.Financial Highlights
          11.12.3.Product Portfolio
          11.12.4.SWOT Analysis
          11.12.5.Key Strategies and Developments
        11.13.Other Key Players
          11.13.1.Company Overview
          11.13.2.Financial Highlights
          11.13.3.Product Portfolio
          11.13.4.SWOT Analysis
          11.13.5.Key Strategies and Developments
      12.Assumptions and Acronyms
      13.Research Methodology
      14.Contact
    If your country is missing in the list, we apologize that we still do not serve in your country.

    Your personal details are safe and secured with us.

    If your country is missing in the list, we apologize that we still do not serve in your country.

    Your personal details are safe and secured with us.

    Select License Type


    • RC-554

    • November-2023
      • ★★★★★
        ★★★★★
      • 47
    • $3190
    • $4590
    • $5690
    Download Free Brochure Customization Request Buy Country Level Reports Request Discount
    Chat on WhatsApp

    Get in Touch with Us

      USA Flag
    • UNITED STATES
      Phone: +1 732 369 9777
      India Flag
    • India
      Phone: +91 882 677 4855

    Recent Report

    • Pharma Quality Assurance Services Market
    • Pharmaceutical Drug Delivery Market
    • Cellulose Insulation Market
    • Remote Patient Monitoring Market
    • Molecular Diagnostics Market
    • Dental Consumables Market
    • Radioimmunoassay Market
    • Home Healthcare Services Market
    • Varicose Vein Treatment Market
    • Sleep Apnea Implants Market
    Secured Payment Options
      /images/payment.png
    Legal
    • Privacy Policy
    • Refund Policy
    • Frequently Asked Questions
    • Terms and Conditions
    Explore Company
    • About Us
    • Contact Us
    • Trending Reports
    • Latest Reports
    • All Industries
    • How to Order
    Contact Detail
    • 957 Route 33, Suite 12 #308
            Hamilton Square, NJ-08690 USA
    • +1 (123) 456 4562 (International)
    • +1 (609) 857 6083 (International)
    • +91 882 677 4855 (Asia)
    • sales@dimensionmarketresearch.com
    Copyright Market Research. ©2025 All rights reserved